drugset / Trial / NCT05655728
Treatment With Metformin in Chinese Children With Alport Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This single-center, prospective, double-blind randomized placebo-controlled trial will evaluate the efficacy and safety of metformin in Chinese children with Alport syndrome who have received (and continue to receive)) ACEi/ARB.
Timeline
- Start
- 2023-01-03
- Primary completion
- 2025-01-31
- Completion
- 2025-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 1500 mg | — |